Skip to main content
Log in

The anticoagulant fraction from the leaves ofDiospyros kaki L. has an antithrombotic activity

  • Articles
  • Drug Design
  • Published:
Archives of Pharmacal Research Aims and scope Submit manuscript

Abstract

The leaves of Persimmon (Diospyros kaki L.) has long been used for tea in Korea since it was thought to be effective against hypertension. An anticoagulant fraction was purified through gel filtration G-100, hydrophobic, gel filtration G-150, and FPLC, Phenyl superpose column chromatographies. The purified fraction was homogenous and its Mr was estimated 10,000 Da by gel filtration and SDS-PAGE. The purified fraction was sensitive to treatment of subtilisin B, but not to heat and its activity was not changed after periodate oxidation, indicating that the activity was not due to carbohydrates. It delayed thrombin time (TT), activated partial thromboplastin time (APTT), and prothrombin time (PT) using human plasma. TT was more sensitive than APTT and PT, suggesting that the anticoagulant activity may be caused by a degradation or a defect of fibrin or thrombin. It did not cause the hydrolysis of fibrin after incubation. However, it inhibited thrombin-catalyzed fibrin formation with a competitive inhibition pattern. These results indicate that it may be an antithrombotic agent and that it is bound to fibrinogen binding sites of thrombin.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Carter, W. J., Myles, T., Gibbs, C. S., Leung, L. L., and Huntington, J. A., Crystal structure of anticoagulant thrombin variant E217K provides insights into thrombin allostery.J. Biol. Chem., 279, 26387–26394 (2004).

    Article  PubMed  CAS  Google Scholar 

  • Cho, J., Seo, H., Yun, C., Koo, B., Yoshida, S., Koga, T., Dan, T., and Kim, H.,in vitro andin vivo stuies of AT-1362, a newly synthesized and orally active inhibitor of thrombin.Thromb. Res., 100, 97–107 (2000).

    Article  PubMed  CAS  Google Scholar 

  • Cho, H. R., and Choi, H. S., Effects of anticoagulant fromSpirodela polyrhiza in rats.Biosci. Biotechnol. Biochem., 67, 881–883 (2003).

    Article  PubMed  CAS  Google Scholar 

  • Choi, H. S., and Sa, Y. S., Fibrinolytic and antithrombotic protease fromSpirodela polyrhiza.Biosci. Biotechnol. Biochem., 65, 781–786, (2001).

    Article  PubMed  CAS  Google Scholar 

  • Friedrich, T., Kroger, B., Bialojan, S., Lemaire, H. G., Hoffken, H. W. Reuschenbach, P., Otte, M., and Dodt, J., A kazal-type inhibitor with thrombin specificity fromRhodnius prolixus.J. Biol. Chem., 286, 16216–16222 (1993).

    Google Scholar 

  • Herbert, J. M., Herault, J. P., Bernat, A., van Amsterdam, R. G. M., Iormeau, J. C., Petitou, M., van Boeckel, C., Hoffmann, P. and Meuleman, D. G., Biochemical and pharmacological properties of Sanorg 34006, a potent and long-acting synthetic pentasaccharide.Blood, 91, 4197–4205 (1998)

    PubMed  CAS  Google Scholar 

  • Hofmann, W., and Bon, C., blood coagulation induced by the venom of Bothrops atrox. 1. Identification, purification, and properties of a prothrombin activator.Biochemistry, 26, 772–776 (1987).

    Article  PubMed  CAS  Google Scholar 

  • Holsat, J., Lindblad, B., and Bergqvist, D., Antithrombotic effect of recombinant truncated tissue factor pathway inhibitor (TFPI1-161) in experimental venous thrombosis-a comparison with low molecular weight heparin.Thromb. Haemost, 71, 214–219 (1994).

    Google Scholar 

  • Jakubowski, J. A., and Maraganore, J. M., Inhibition of coagulation and thrombin-induced platelet activities by a synthetic dodecapeptide modeled on the carboxy-terminus of hirudin.Blood, 75, 399–406 (1990).

    PubMed  CAS  Google Scholar 

  • Kang, K. T., Jung, B. I., Bae, O. N., Lee, M. Y., Chung, S. M., Lee, J. Y., Lee, S. K., Kim, I. C., and Chung, J. H., Antithrombotic activity of LB30057, a newly synthesized direct thrombin inhibitor.Thromb. Haemost., 89, 104–111 (2003).

    PubMed  CAS  Google Scholar 

  • Lettino, M., and Toschi, V., Direct antithrombins: new perspectives in cardiovascular medicine.Curr. Med. Chem. Cardiovasc. Hematol. Agents, 2, 267–275 (2004).

    Article  PubMed  CAS  Google Scholar 

  • Liu, F., Craft, R. M., Morris, S. A., and Carroll, R. C., Lotrafiban: an oral platelet glycoprotein IIb/IIIa blocker.Expert. Opin. Investig. Drugs, 9, 2673–2687 (2000).

    Article  PubMed  CAS  Google Scholar 

  • Markwardt, F., Hirudin as alternative anticoagulant-a historical review.Semin. Thromb. Hemost., 28, 405–414 (2002).

    Article  PubMed  CAS  Google Scholar 

  • McClanahan, T. B., Hicks, G. W., Morrison, A. L., Peng, Y. W., Janiczek-Dolphin, N., Mertz, T. E., Sullivan, M. E., Morser, J., Juneau, P. L., and Leadley, R., The antithrombotic effects of CI-1031 (ZK-807834) and enoxaparin in a canine electrolytic injury model of arterial and venous thrombosis.Eur. J. Pharmacol., 432, 187–194 (2001).

    Article  PubMed  CAS  Google Scholar 

  • McGowan, E. B., and Detwiler, T. C., Modified platelet responses to thrombin. Evidence for two types of receptors or coupling mechanisms.J. Biol. Chem., 261, 739–746 (1986).

    PubMed  CAS  Google Scholar 

  • Moon, K. S., In Usage of Herbal Medicine (ed. Choi, O. J.), pp 466–468, Ilwolseogak (1991).

  • Muramatsu, R., Sasaki, M., Watanabe, N., Goto, Y., Okayama, T., Nukui, E., Morikawa, T., and Hayashi, H., Antithrombotic effects of NE-6505, a novel anion-binding exosite inhibitor.Thromb. Res., 86, 453–460 (1997).

    Article  PubMed  CAS  Google Scholar 

  • Naski, M. C., Fenton, J. W., Maraganore, J. M., Olson, S. T., and Shafer, J. A., The COOH-terminal domain of hirudin.J. Biol. Chem., 265, 13484–13489 (1990).

    PubMed  CAS  Google Scholar 

  • Noeske-Jungblut, C., Haendler, B., Donner, P., Alagon, A., Possani, L., and Schleu ning, W-D., Triabin, a highly potent exosite inhibitor of thrombin.J. Biol. Chem., 270, 28629–28634 (1995).

    Article  PubMed  CAS  Google Scholar 

  • Okonogi, T., Hattori, Z., Ogiso, A., and Mitsui, S., Detoxification by persimmon tannin of snake venoms and bacterial toxins.Toxicon, 17, 524–527 (1979).

    Article  PubMed  CAS  Google Scholar 

  • Olson, S. T., Bjo, I., Sheffer, R., Craig, P. A., Shore, J. D., and Choay, J., Role of the antithrombin-binding pentasaccharides in heparin acceleration of antithrombin-proteinase reactions.J. Biol. Chem., 267, 12528–12538 (1992).

    PubMed  CAS  Google Scholar 

  • Rezaie, A. R., Cooper, S. T., Church, F. C., and Esmon, C. T., Protein C inhibitor is a potent inhibitor of the thrombin-thrombomodulin complex.J. Biol. Chem., 270, 25336–25339 (1995).

    Article  PubMed  CAS  Google Scholar 

  • Renda, G., Rocca, B., Crocchiolo, R., Cristofaro, R. D., and Landolfi, R., Effect of fibrinogen concentration and platelet count on the inhibitory effect of abciximab and tirofiban.Thromb. Haemost., 89, 348–354 (2003).

    PubMed  CAS  Google Scholar 

  • Richardson, J. L., Kroger, B., Hoeffken, W., Sadler, J. E., Pereira, P., Huber, R., Bode, W., and Fuentes-Prior, P., Crystal structure of the human alpha-thrombin-haemadin complex: an exosite II-binding inhibitor.EMBO J., 19, 5650–5660 (2000).

    Article  PubMed  CAS  Google Scholar 

  • Sa, Y. S., Kim, K. A., and Choi, H. S., Purification and characterization of anti-coagulant activity from persimmon stem.J. Kor. Soc. Food Sci. Nutr., 32, 1323–1327 (2003).

    CAS  Google Scholar 

  • Strube, K.-H., Kroger, B., Bialojan, S., Otte, M., and Dodt, J. Isolation, sequence analysis, and cloning of haemadin.J. Biol. Chem., 268, 8590–8595 (1993).

    PubMed  CAS  Google Scholar 

  • Stubbs, M. T., Oschkinat, H., Mayr, I., Huber, R., Angliker, H., Stone, S. R., and Bode, W., The interaction of thrombin with fibrinogen. A structural basis for its specificity.Eur. J. Biochem., 206, 187–195 (1992).

    Article  PubMed  CAS  Google Scholar 

  • Tsiang, M., Lentz, S. R., Dittman, W. A., Wen, D., Scarpati, E. M., and Sadler, J. E., Equilibrium binding of thrombin to recombinant human thrombomodulin: effect of hirudin, fibrinogen, factor Va, and peptide analogues.Biochemistry, 29, 10602–10612 (1990).

    Article  PubMed  CAS  Google Scholar 

  • Wall, D., Douglas, S., Ferro, V., Cowden, W., and Parish, C., Characterisation of the anticoagulant properties of a range of structurally diverse sulfated oligosaccharides.Thromb. Res., 103, 325–335 (2001).

    Article  PubMed  CAS  Google Scholar 

  • Wong, P. C., Crain, E. J., Watson, C. A., Zaspel, A. M., Wright, M. R., Lam, P. Y., Pinto, D. J., Wexler, R. R., and Knabb, R. M., Nonpeptide factor Xa inhibitors III: effects of DPC423, an orally-active pyrazole antithrombotic agent, on arterial thrombosis in rabbits.J. Pharmacol. Exp. Ther., 303, 993–1000 (2002).

    Article  PubMed  CAS  Google Scholar 

  • Yuk, D. Y., Ryu, C. K., Hong, J. T., Chung, K. H., Kang, W. S., Kim, Y., Yoo, H. S., Lee, M. K., Lee, C. K., and Yun, Y. P., Antithrombotic and antiplatelet activities of 2-chloro-3-[4-(ethylcarboxy)-phenyl]-amino-1,4-naphthoquinone (NQ12), a newly synthesized 1,4-napthoquinone derivative.Biochem. Pharmacol., 60, 1001–1008 (2000).

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hye-Seon Choi.

Additional information

S. J. Kim was supported by BK21 of University of Ulsan (2003–2005).

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sa, Y.S., Kim, SJ. & Choi, HS. The anticoagulant fraction from the leaves ofDiospyros kaki L. has an antithrombotic activity. Arch Pharm Res 28, 667–674 (2005). https://doi.org/10.1007/BF02969356

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02969356

Key words

Navigation